Skip to content

Comparison of the Postoperative Analgesic Effects of SPSIPB and TPB in Mastectomy Operations

Comparison of the Postoperative Analgesic Effects of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in Mastectomy Operations

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06789146
Enrollment
60
Registered
2025-01-23
Start date
2025-02-12
Completion date
2026-02-23
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy, Pain Management, Peripheral Nerve Block

Keywords

Mastectomy, Serratus Posterior Superior Intercostal Plane Block, Thoracic Paravertebral Block

Brief summary

Breast cancer is the most common malignancy in women, and surgery is one of the cornerstone treatments for breast cancer. Postoperative pain can significantly reduce patients' quality of life and acute pain may even trigger chronic pain syndrome. Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications. In this study; it was aimed to compare the analgesic effectiveness of serratus posterior superior intercostal plane block and thoracic paravertebral block in the postoperative period in patients who underwent mastectomy.

Interventions

PROCEDURESerratus posterior superior intercostal plane block

Serratus posterior superior intercostal plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.

PROCEDUREThoracic Paravertebral Block

Thoracic paravertebral block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-80 years * American Society of Anesthesiologists (ASA) score I-II-III * Body Mass Index (BMI) between 18-30 kg/m2

Exclusion criteria

* Patients under 18 and over 80 years of age * ASA score IV and above * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Pain ScoresOn the operation dayPain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be done at 0st, 1st, 2nd,4th, 12th, and 24th hours after surgery.

Secondary

MeasureTime frameDescription
Intraoperative opioid consumptionIntraoperative periodRemifentanil consumption for intraoperative period will be recorded
Postoperative Tramadol ConsumptionOn the operation dayTramadol consumption for 24 hours will be recorded

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026